171 related articles for article (PubMed ID: 25232251)
1. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.
Xu HL; Zhao X; Zhang KM; Tang W; Kokudo N
World J Gastroenterol; 2014 Sep; 20(34):12171-81. PubMed ID: 25232251
[TBL] [Abstract][Full Text] [Related]
2. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
3. Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion.
Xu HL; Inagaki Y; Seyama Y; Sugawara Y; Kokudo N; Nakata M; Wang FS; Tang W
Life Sci; 2009 Aug; 85(9-10):395-400. PubMed ID: 19631667
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the O-glycan elongation limits MUC1 incorporation to cell membrane of human endometrial carcinoma cells.
Porowska H; Paszkiewicz-Gadek A; Anchim T; Wolczynski S; Gindzienski A
Int J Mol Med; 2004 Mar; 13(3):459-64. PubMed ID: 14767580
[TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
Lüttges J; Zamboni G; Longnecker D; Klöppel G
Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
[TBL] [Abstract][Full Text] [Related]
6. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition.
Roy LD; Sahraei M; Subramani DB; Besmer D; Nath S; Tinder TL; Bajaj E; Shanmugam K; Lee YY; Hwang SI; Gendler SJ; Mukherjee P
Oncogene; 2011 Mar; 30(12):1449-59. PubMed ID: 21102519
[TBL] [Abstract][Full Text] [Related]
7. Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain.
Kalra AV; Campbell RB
Br J Cancer; 2007 Oct; 97(7):910-8. PubMed ID: 17912239
[TBL] [Abstract][Full Text] [Related]
8. Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours.
Kalra AV; Campbell RB
Eur J Cancer; 2009 Jan; 45(1):164-73. PubMed ID: 19046630
[TBL] [Abstract][Full Text] [Related]
9. Effect of benzyl-N-acetyl-α-galactosaminide on KL-6 mucin expression and invasive properties of a human pancreatic carcinoma cell line.
Xu HL; Inagaki Y; Wang FS; Kokudo N; Nakata M; Tang W
Drug Discov Ther; 2008 Oct; 2(5):282-5. PubMed ID: 22504721
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic analysis of 92 cases of pancreatic cystic neoplasm].
Ji Y; Zhu XZ; Lou WH; Wang DQ; Jin DY; Zeng MS; Zeng HY
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):160-5. PubMed ID: 17535681
[TBL] [Abstract][Full Text] [Related]
11. Pivotal role of MUC1 glycosylation by cigarette smoke in modulating disruption of airway adherens junctions in vitro.
Zhang L; Gallup M; Zlock L; Chen YT; Finkbeiner WE; McNamara NA
J Pathol; 2014 Sep; 234(1):60-73. PubMed ID: 24838315
[TBL] [Abstract][Full Text] [Related]
12. MUC1 regulates PDGFA expression during pancreatic cancer progression.
Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P
Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848
[TBL] [Abstract][Full Text] [Related]
13. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
[TBL] [Abstract][Full Text] [Related]
14. Biphasic Alterations in Expression and Subcellular Localization of MUC1 in Pancreatic Ductal Carcinogenesis in Syrian Hamsters.
Kitahashi T; Takahashi M; Imai T
Pancreas; 2015 Jan; 44(1):76-86. PubMed ID: 25036908
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of MUC1 expression to adhesion of breast cancer cell line MDA-MB-231].
Lu L; Deng HY; Fan WK
Ai Zheng; 2004 Nov; 23(11):1294-6. PubMed ID: 15522176
[TBL] [Abstract][Full Text] [Related]
16. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
17. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
Yonezawa S; Nakamura A; Horinouchi M; Sato E
J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of KL-6 in the subtyping of intraductal papillary mucinous neoplasia of the pancreas, including carcinoma, dysplasia, and hyperplasia.
Ohtsuki Y; Watanabe R; Kimura M; Nomura K; Maeda T; Kito K; Takeji M; Lee GH; Furihata M
Med Mol Morphol; 2015 Jun; 48(2):85-91. PubMed ID: 24908068
[TBL] [Abstract][Full Text] [Related]
19. TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells.
Zheng B; Ohuchida K; Cui L; Zhao M; Shindo K; Fujiwara K; Manabe T; Torata N; Moriyama T; Miyasaka Y; Ohtsuka T; Takahata S; Mizumoto K; Oda Y; Tanaka M
Int J Oncol; 2015 Aug; 47(2):490-8. PubMed ID: 26035794
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of the association between the progression of pancreatic ductal lesions and the expression of MUC1, MUC2, MUC5AC, and E-cadherin.
Kigure S
Rinsho Byori; 2006 May; 54(5):447-52. PubMed ID: 16789413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
